**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 1308-06-1 |Cobalt oxide Co3O4 | 100 | 215-157-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN N
Risk Phrases: 22 43 50/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. May cause sensitization by skin contact. Very
toxic to aquatic organisms, may cause long-term adverse effects in
the aquatic environment.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May cause skin sensitization, an allergic
reaction, which becomes evident upon re-exposure to this material.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May cause chronic airway
hyperreactivity and asthma, with changes in pulmonary function.
Chronic:
Cobalt compounds may cause cancer based upon animal studies. May
cause chronic heart disease due to effects on the heart muscle.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid.
Skin:
In case of contact, immediately flush skin with soap and plenty of
water. Remove contaminated clothing and shoes. Get medical aid if
symptoms occur. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Runoff from fire control or dilution water may
cause pollution.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Use with adequate ventilation. Minimize dust generation and
accumulation. Avoid contact with eyes, skin, and clothing. Keep
container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 1307-96-6:
United Kingdom, WEL - TWA: (listed as cobalt compounds): 0.1 mg/m
TWA (as Co)
United Kingdom, WEL - STEL: (listed as cobalt compounds): 0.3 mg/
STEL (as Co)
Japan: (listed as cobalt compounds): 0.05 mg/m3 OEL (as Co)
Malaysia: (listed as cobalt, inorganic compounds): 0.02 mg/m3 TWA
Co)
Spain: (listed as cobalt, inorganic compounds): 0.02 mg/m3 VLA-ED
Co)
CAS# 1308-06-1:
United Kingdom, WEL - TWA: (listed as cobalt compounds): 0.1 mg/m
TWA (as Co)
United Kingdom, WEL - STEL: (listed as cobalt compounds): 0.3 mg/
STEL (as Co)
Japan: (listed as cobalt compounds): 0.05 mg/m3 OEL (as Co)
Malaysia: (listed as cobalt, inorganic compounds): 0.02 mg/m3 TWA
Co)
Spain: (listed as cobalt, inorganic compounds): 0.02 mg/m3 VLA-ED
Co)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: black-gray
Odor: Not available.
pH: Not available.
Vapor Pressure: Not applicable.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 895 deg C (dec)
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 895 deg C
Solubility in water: insoluble
Specific Gravity/Density: 6.11 g /cm3
Molecular Formula: O4Co3
Molecular Weight: 240.80
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Dust generation, moisture, excess heat.
Incompatibilities with Other Materials:
No information found..
Hazardous Decomposition Products:
Cobalt/cobalt oxides.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1307-96-6: GG2800000
CAS# 1308-06-1: GG2500000
LD50/LC50:
CAS# 1307-96-6: Oral, rat: LD50 = 202 mg/kg; Oral, rat: LD50 = 202
mg/kg.
CAS# 1308-06-1: Oral, rat: LD50 = >5 gm/kg.
Carcinogenicity:
Cobalt(II) oxide -
California: carcinogen, initial date 7/1/92
Cobalt oxide Co3O4 -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN N
Risk Phrases:
R 22 Harmful if swallowed.
R 43 May cause sensitization by skin contact.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 22 Do not breathe dust.
S 24 Avoid contact with skin.
S 37 Wear suitable gloves.
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 1307-96-6: 2
CAS# 1308-06-1: 0
Canada
CAS# 1307-96-6 is listed on Canada's DSL List.
CAS# 1308-06-1 is listed on Canada's DSL List.
CAS# 1307-96-6 is listed on Canada's Ingredient Disclosure List.
CAS# 1308-06-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1307-96-6 is listed on the TSCA inventory.
CAS# 1308-06-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 9/02/1997 Revision #7 Date: 1/22/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Cobalt (II) Nitrate Hexahydrate
| 10026-22-9 |
|
Stearyl stearate
| 2778-96-3 |
|
Glycerine trioleate
| 122-32-7 |
|
5-Bromo-4-chloro-3-indoxyl-??-D-xylopyranoside
| 207606-55-1 |
|
Cobalt oxide
| 1307-96-6 |
|
2-(6-Bromonaphthyl)-??-D-xylopyranoside hydrate
| 0-01-1 |
|
5-(4-Fluorophenyl)valeric acid
| 24484-22-8 |
|
6-Methoxyindole
| 3189-13-7 |
|
Alpha,Alpha-Trehalose, 99+%
| 99-20-7 |
|
3-Amino-9-fluorenone
| 6276-05-7 |
|
Methyl linolenate
| 301-00-8 |
|
5-Bromo-4-chloro-3-indoxyl butyrate
| 129541-43-1 |
|
6-Amino-1-methyluracil, 97%
| 2434-53-9 |
|
2,3-Dimethylbenzofuran, 99%
| 3782-00-1 |
|
6-Amino-1-methyl-5-nitrosouracil, 97%
| 6972-78-7 |
|
2-Aminoethyl dihydrogen phosphate, 95%
| 1071-23-4 |
|
4-Iodophenoxymethyl polystyrene resin, 1% cross-linked with DVB,
| 00-01-1 |
|
Iodo polystyrene resin, 50-100 mesh
| 00-01-1 |
|
(+/-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl
| 98327-87-8 |
|
4,6-Dimethoxysalicylaldehyde
| 708-76-9 |
|
Acid orange 63
| 15792-50-4 |
|
N-BOC-L-tert-Leucine
| 62965-35-9 |
|
5-Nitro-3-pyrazolecarboxylic acid
| 198348-89-9 |
|
3,4,5-Trifluorophenylboronic acid
| 143418-49-9 |
|
2-Fluoro-4-hydroxybenzonitrile
| 82380-18-5 |
|
Guanosine Hydrate, 99%
| 118-00-3 |
|
(1S,2R)-2-Amino-1,2-diphenylethanol
| 23364-44-5 |
|
2-Amino-4-(trifluoromethyl)benzenethiol hydrochloride
| 4274-38-8 |
|
o-Toluic hydrazide
| 7658-80-2 |
|
Sodium glycocholate hydrate
| 207614-05-9 |
|
1,11-Undecanedicarboxylic acid, 94%
| 505-52-2 |
|
1-Decanesulfonic acid, sodium salt, 96%
| 13419-61-9 |
|
4-Chloro-5-(2-thienyl)thieno[2,3-d]pyrimidine, 97%
| 189681-04-7 |
|
2-Methyl-4-(2-thienyl)-1,3-thiazole, 90+%
| 21036-67-9 |
|
3-(Oxiran-2-ylmethoxy)benzaldehyde, 97%
| 22590-64-3 |
|
2-(1,4-Diazepan-1-yl)ethan-1-ol, 97%
| 53427-65-9 |
|
1-[3-Chloro-5-(trifluoromethyl)-2-pyridyl]-1,4-diazepane, 97%
| 231953-40-5 |
|
Cobalt (II) acetate tetrahydrate
| 6147-53-1 |
|
tert-Butyl 1,4-diazepane-1-carboxylate, 97%
| 112275-50-0 |
|
Tris-(4-Bromophenyl)-Aminium Hexachloro-Antimonate, 98%
| 24964-91-8 |
|
tert-Butyl n-(2-aminoethyl)carbamate, 97%
| 57260-73-8 |
|
5-(1,4-Diazepan-1-yl)-3-phenyl-1,2,4-thiadiazole, 97%
| 306934-71-4 |
|
tert-Butyl n-{2-[2-amino-4-(trifluoromethyl)anilino]ethyl}carbamate,
| 215655-42-8 |
|
tert-Butyl 4-(2-hydroxyethyl)piperazine-1-carboxylate, 97%
| 77279-24-4 |
|
1-[4-(Trifluoromethyl)pyrimidin-2-yl]-1,4-diazepane, 97%
| 238403-48-0 |
|
1-(2-Chloro-6-fluorobenzyl)-1,4-diazepane, 97%
| 244022-69-3 |
|
1-(4-Fluorobenzyl)-1,4-diazepane, 97%
| 76141-89-4 |
|
1-(2-Chloro-6-fluorobenzyl)piperazine, 97%
| 215655-20-2 |
|
1-(5-Nitro-2-pyridyl)-1,4-diazepane, 97%
| 287114-27-6 |
|
N-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]propane-1,3-diamine, 95+%
| 465514-63-0 |
|
|